M/Z: 586.2406


Hit 1 annotations:  Taurolithocholate 3-sulfate_[M+Na]+


在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 4 Reference Ions Near m/z 586.2406
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000061137 Unreliable 586.2317 586.2317 ~ 586.2317
MzDiff: 0.1 ppm
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione (BioDeep_00000172564)
Formula: C30H35NO11 (585.221)
3.29 (100%) Mus musculus
[UBERON:0000956] cerebral cortex
MSI_000060154 Unavailable 586.2309 586.2309 ~ 586.2309
MzDiff: none
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione (BioDeep_00000172564)
Formula: C30H35NO11 (585.221)
-1.09 (100%) Mus musculus
[UBERON:0002298] brainstem
MSI_000060282 Unreliable 586.2309 586.2309 ~ 586.2309
MzDiff: none
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione (BioDeep_00000172564)
Formula: C30H35NO11 (585.221)
0.87 (100%) Mus musculus
[UBERON:0002421] hippocampal formation
MSI_000065905 Unreliable 586.2318 586.2318 ~ 586.2318
MzDiff: none
9-Ethyl-4,6,9,10,11-pentahydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-8,10-dihydro-7H-tetracene-5,12-dione (BioDeep_00000172564)
Formula: C30H35NO11 (585.221)
1.15 (100%) Homo sapiens
[UBERON:0007779] transudate

Found 1 Sample Hits
Metabolite Species Sample
Taurolithocholate 3-sulfate

Formula: C26H45NO8S2 (563.2586)
Adducts: [M+Na]+ (Ppm: 12.4)
Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).